Patents by Inventor Dean Petkanas

Dean Petkanas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FUNCTIONALIZED 1,3-BENZENE DIOLS AND THEIR METHOD OF USE FOR THE TREATMENT OF INFLAMMATION AND PAIN
    Publication number: 20240131004
    Abstract: A method of treating or preventing inflammation and pain includes administering to a subject a functionalized 1,3-benzene diol represented by a formula selected from formulas (I)-(X) as defined herein, and hydrates, solvates, pharmaceutically acceptable salts, and complexes thereof. Further disclosed is a chemotherapeutic method, including administering to a patient: (1) at least one chemotherapeutic agent and (2) at least one functionalized 1,3-benzene diol represented by a formula selected from formulas (I)-(X) as defined herein, and hydrates, solvates, pharmaceutically acceptable salts, and complexes thereof, which is effective to treat or prevent inflammation and pain associated with administering the at least one chemotherapeutic agent.
    Type: Application
    Filed: January 31, 2022
    Publication date: April 25, 2024
    Inventors: Douglas BRENNEMAN, William A. KINNEY, Mark E. MCDONNELL, Dean PETKANAS
  • FUNCTIONALIZED 1,3-BENZENE DIOLS AND THEIR METHOD OF USE FOR THE TREATMENT OF RADIATION DERMATITIS AND OTHER SKIN DISORDERS
    Publication number: 20220409578
    Abstract: Methods, compounds and compositions for treating and preventing dermatological disorders and ocular irritancy are disclosed. The compounds and compositions comprise a functionalized 1,3-benzene diol, such as 5-(2-(1H-1,2,3-triazol-1-yl)ethyl)-2-((1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-enyl)benzene-1,3-diol and ethyl 3-(3,5-dihydroxy-4-((1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-enyl)benzyl)azetidine-1-carboxylate.
    Type: Application
    Filed: November 13, 2020
    Publication date: December 29, 2022
    Inventors: Douglas BRENNEMAN, William A. KINNEY, Mark E. MCDONNELL, Dean PETKANAS
  • USE OF CERTAIN PHOSPHATIDYLCHOLINES CONTAINING LONG CHAIN POLYUNSATURATED FATTY ACIDS AS NEUROPROTECTIVE AGENTS
    Publication number: 20220257620
    Abstract: The invention relates to compositions containing certain phosphatidylcholines containing long chain polyunsaturated fatty acids in the sn-1 position or both the sn-1 and sn-2 positions as a neuroprotective agent, and further to treating or preventing oxidative stress in a neuronal tissue with such compositions.
    Type: Application
    Filed: June 26, 2020
    Publication date: August 18, 2022
    Inventors: Douglas E. BRENNEMAN, William A. KINNEY, Jason CLEMENT, Dean PETKANAS
  • Method for treating hepatic encephalopathy or a disease associated with free radical mediate stress and oxidative stress with novel functionalized 1,3-benzene diols
    Patent number: 10004722
    Abstract: Pharmaceutical compositions of the invention include novel functionalized 1,3-benzenediols having a disease-modifying action in the treatment of hepatic encephalopathy and related conditions. Pharmaceutical compositions of the invention further include novel neuroprotective agents.
    Type: Grant
    Filed: February 20, 2017
    Date of Patent: June 26, 2018
    Assignee: KANNALIFE SCIENCES, INC.
    Inventors: Douglas E. Brenneman, William Alvin Kinney, Mark McDonnell, Dean Petkanas
  • METHOD FOR TREATING HEPATIC ENCEPHALOPATHY OR A DISEASE ASSOCIATED WITH FREE RADICAL MEDIATE STRESS AND OXIDATIVE STRESS WITH NOVEL FUNCTIONALIZED 1,3-BENZENE DIOLS
    Publication number: 20170157097
    Abstract: Pharmaceutical compositions of the invention include novel functionalized 1,3-benzenediols having a disease-modifying action in the treatment of hepatic encephalopathy and related conditions. Pharmaceutical compositions of the invention further include novel neuroprotective agents.
    Type: Application
    Filed: February 20, 2017
    Publication date: June 8, 2017
    Inventors: Douglas E. BRENNEMAN, William Alvin KINNEY, Mark MCDONNELL, Dean PETKANAS
  • Functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathy
    Patent number: 9611213
    Abstract: Pharmaceutical compositions of the invention include novel functionalized 1,3-benzenediols having a disease-modifying action in the treatment of hepatic encephalopathy and related conditions. Pharmaceutical compositions of the invention further include novel neuroprotective agents.
    Type: Grant
    Filed: January 9, 2015
    Date of Patent: April 4, 2017
    Assignee: KANNALIFE SCIENCES, INC.
    Inventors: Douglas E Brenneman, William Alvin Kinney, Mark McDonnell, Dean Petkanas
  • NOVEL FUNCTIONALIZED 1,3-BENZENE DIOLS AND THEIR METHOD OF USE FOR THE TREATMENT OF HEPATIC ENCEPHALOPTHY
    Publication number: 20160311769
    Abstract: Pharmaceutical compositions of the invention include novel functionalized 1,3-benzenediols having a disease-modifying action in the treatment of hepatic encephalopathy and related conditions. Pharmaceutical compositions of the invention further include novel neuroprotective agents.
    Type: Application
    Filed: January 9, 2015
    Publication date: October 27, 2016
    Inventors: Douglas E Brenneman, William Alvin Kinney, Mark McDonnell, Dean Petkanas